Molecular heterogeneity of inflammatory breast cancer: a hyperproliferative phenotype
- PMID: 16951220
- DOI: 10.1158/1078-0432.CCR-05-2248
Molecular heterogeneity of inflammatory breast cancer: a hyperproliferative phenotype
Abstract
Purpose: Inflammatory breast cancer (IBC) is associated with very poor prognosis. The aims of this study are (a) to prospectively identify differential gene expression patterns associated with IBC and (b) to confirm these pathways using tissue arrays.
Experimental design: For gene expression analysis, IBC (n=14) was clinically defined as rapid-onset cancer associated with erythema and skin changes, whereas non-IBC patients (n=20) had stage III breast cancers, and cDNA analysis was carried out using the Affymetrix (Santa Clara, CA) HG-U133A microarrays. Tissue arrays were constructed from paraffin-embedded material, and the molecular phenotype of 75 IBC was compared with results from>2,000 non-IBC.
Results: Gene expression analyses indicated that IBC has higher expression of genes associated with increased metabolic rate, lipid signaling, and cell turnover relative to non-IBC tumors. Consistent with the expression analysis, IBC had statistically higher Ki-67 (93% versus 11%; P<0.001). BAX expression, reflecting increased apoptosis and cell turnover, was significantly uniformly higher in almost all IBC (98% versus 66%; P<0.05), whereas the expression of Bcl-2 was not significantly different. IBC tumors were more likely to be steroid hormone receptor negative (estrogen receptor, 49% versus 30%; P=0.002; progesterone receptor, 68% versus 42%; P=0.001). The expression of tyrosine kinases was not significantly different. E-cadherin was found to be expressed in 87% of IBC, whereas the expression p53 was not significantly different.
Conclusion: This study is one of the largest molecular analyses of IBC. Both IBC and non-IBC are genetically heterogeneous with consistent differences in the molecular phenotype of IBC.
Similar articles
-
Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-binding.Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3249-56. doi: 10.1158/1078-0432.CCR-05-2800. Clin Cancer Res. 2006. PMID: 16740744
-
Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.Breast Cancer Res Treat. 2006 Feb;95(3):219-28. doi: 10.1007/s10549-005-9002-1. Epub 2005 Oct 22. Breast Cancer Res Treat. 2006. PMID: 16244790
-
Persistent E-cadherin expression in inflammatory breast cancer.Mod Pathol. 2001 May;14(5):458-64. doi: 10.1038/modpathol.3880334. Mod Pathol. 2001. PMID: 11353057
-
Gene expression profiling of inflammatory breast cancer.Cancer. 2010 Jun 1;116(11 Suppl):2783-93. doi: 10.1002/cncr.25165. Cancer. 2010. PMID: 20503410 Review.
-
[High-throughput quantification of tissue microarrays: identification of candidate target proteins in inflammatory breast cancer].Bull Acad Natl Med. 2007 Feb;191(2):361-74; discussion 374-6. Bull Acad Natl Med. 2007. PMID: 17969554 Review. French.
Cited by
-
CASP9 As a Prognostic Biomarker and Promising Drug Target Plays a Pivotal Role in Inflammatory Breast Cancer.Int J Anal Chem. 2022 Sep 25;2022:1043445. doi: 10.1155/2022/1043445. eCollection 2022. Int J Anal Chem. 2022. PMID: 36199443 Free PMC article.
-
Identification of genes with high heterogeneity of expression as a predictor of different prognosis and therapeutic responses in colorectal cancer: a challenge and a strategy.Cancer Cell Int. 2022 Sep 5;22(1):276. doi: 10.1186/s12935-022-02694-9. Cancer Cell Int. 2022. PMID: 36064367 Free PMC article.
-
Toward precision medicine in inflammatory breast cancer.Transl Cancer Res. 2019 Oct;8(Suppl 5):S469-S478. doi: 10.21037/tcr.2019.05.04. Transl Cancer Res. 2019. PMID: 35117125 Free PMC article. Review.
-
Group and Basis Restricted Non-Negative Matrix Factorization and Random Forest for Molecular Histotype Classification and Raman Biomarker Monitoring in Breast Cancer.Appl Spectrosc. 2022 Apr;76(4):462-474. doi: 10.1177/00037028211035398. Epub 2021 Aug 6. Appl Spectrosc. 2022. PMID: 34355582 Free PMC article.
-
Identification of Potential Key Genes and Pathways for Inflammatory Breast Cancer Based on GEO and TCGA Databases.Onco Targets Ther. 2020 Jun 12;13:5541-5550. doi: 10.2147/OTT.S255300. eCollection 2020. Onco Targets Ther. 2020. PMID: 32606769 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous